SPARC IBD Study

SPARC IBD—Study of a Prospective Adult Research Cohort with IBD—is a multicentered longitudinal study of adult IBD patients.

[Crohn's & Colitis Foundation @CrohnsColitisFn]

As part of #CCAwarenessWeek, we are making #IBDvisible by demystifying diet & nutrition. View educational resources about diet & nutrition, including Gut Friendly Recipes, which includes over 500 recipes vetted by dietitians who specialize in IBD, here: https://t.co/3zXN3OncKl

[SPARC IBD Study @SPARCIBD]

The Microbiome in Quiescent Crohn’s Disease with Persistent Symptoms S... https://t.co/jQHcQgkQ3W

[Crohn's & Colitis Foundation @CrohnsColitisFn]

Are you ready to make #IBDVisible? See all of the ways you can get involved in #CCAwarenessWeek here: https://t.co/vXjFOETXMO

[SPARC IBD Study @SPARCIBD]

Extra-Intestinal Manifestations of Inflammatory Bowel Disease are Associated with Increased Biologic Cycling | Crohn's & Colitis 360
https://t.co/K86bMNhApv

[SPARC IBD Study @SPARCIBD]

Dynamics of the Gut Mycobiome in Patients with Ulcerative Colitis - Clinical Gastroenterology and Hepatology (https://t.co/fOMlX1XRRa)

[Shrinivas Bishu @IBDimmunology]

study by my talented colleague @ryanungaro in @AGA_CGH

✅UST > VDZ after aTNF in 2 seperate cohorts (@MSHS_IBDCenter, @SPARCIBD)

I’m excited cause…This study used data from @SPARCIBD @CrohnsColitisFn

Check @SPARCIBD for your next research!!

https://t.co/PGmG9HlmgZ

[Crohn's & Colitis Foundation @CrohnsColitisFn]

Please join us in welcoming our new Chief Scientific Officer, @moss_md! Learn more about Dr. Moss here: https://t.co/Sy1yHczAOo

[SPARC IBD Study @SPARCIBD]

Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning

https://t.co/82akdYs6Rx

[SPARC IBD Study @SPARCIBD]

The Fecal Microbiome in Quiescent Crohn's Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers

https://t.co/74zfXiMPHU

[SPARC IBD Study @SPARCIBD]

Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning

https://t.co/82akdYrz1Z

[SPARC IBD Study @SPARCIBD]

Second–Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real–World Propensity Score–Weighted Analysis - Clinical Gastroenterology and Hepatology (https://t.co/fOMlX1XRRa)

[Crohn's & Colitis Foundation @CrohnsColitisFn]

We asked our community what topic they want to learn about for our next MyIBD Learning webinar, and the results are in! Our next webinar will be Exploring Blood and Stool Tests in IBD. Register here to join us on June 14 at 8 p.m. ET: https://t.co/6iEJt127Sb

[SPARC IBD Study @SPARCIBD]

A new paper was published using SPARC data!

https://t.co/UnKxs0shr1

[Crohn's & Colitis Foundation @CrohnsColitisFn]

Clinical Trials Day is May 20! Learn more about our Clinical Trials Community and how you can participate in research here: https://t.co/vI3PAGOtsS

[SPARC IBD Study @SPARCIBD]

Excited to share this Request for Information!

https://t.co/mTdFkbwcmB